List of Studies ( Metabolite:Val-Asp)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004389 | AN007334 | Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows | Feces | Pig | Environmental stress | North Carolina State University | LC-MS |
| ST004389 | AN007334 | Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows | Milk | Pig | Environmental stress | North Carolina State University | LC-MS |
| ST004153 | AN006895 | Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model | Feces | Rat | Shanghai Jiao Tong University | LC-MS | |
| ST003911 | AN006421 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Bacterial cells | Eggerthella lenta | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003911 | AN006421 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Bacterial cells | Fusobacterium nucleatum | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Bifidobacteria | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Clostridium | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Escherichia coli | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Streptococcus | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006254 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Neurodevelopment Disorder | Broad Institute of MIT and Harvard | LC-MS |
| ST003805 | AN006254 | Epigenetic changes, neuronal dysregulation and behavioral abnormalities in Zmym2+/- mutant mice, a genetic animal model of schizophrenia and neurodevelopmental disorders | Brain | Mouse | Schizophrenia | Broad Institute of MIT and Harvard | LC-MS |
| ST003799 | AN006244 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 2. | Cultured cells | Dorea longicatena | Colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003565 | AN005857 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003224 | AN005286 | The Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD0156 is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase and is an Attractive Candidate for Repositioning Against Malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST003179 | AN005221 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003160 | AN005184 | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003144 | AN005159 | On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003066 | AN005022 | Heritability of RBC metabolites: baseline correlation of metabolites and markers of RBC health and stability | Erythrocytes | Human | University of Iowa | Other | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | LC-MS | |
| ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | LC-MS | |
| ST002792 | AN004542 | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
| ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
| ST002747 | AN004455 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
| ST002747 | AN004455 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
| ST002512 | AN004137 | Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta | Intestine | Mouse | University of California, San Francisco | LC-MS | |
| ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002472 | AN004037 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula cell and media profiling | Bacterial cells | Veillonella parvula | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002471 | AN004033 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002407 | AN003924 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract | Intestine | Human | University of California, Davis | LC-MS | |
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002078 | AN003387 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003388 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003389 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003390 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003277 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003278 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002009 | AN003275 | Metabolomics analysis of stress erythroid progenitors | Stem cells | Mouse | Inflammation | Pennsylvania State University | LC-MS |
| ST002007 | AN003270 | Isotope tracing analysis of stress erythroid progenitors | Cultured cells | Mouse | Inflammation | Pennsylvania State University | LC-MS |
| ST001955 | AN003180 | Metabonomics analysis reveals the physiological mechanism of promoting maize shoots growth under negative pressure to stabilize soil water content | Leaf | Maize | Heilongjiang Bayi Agricultural University | APCI-MS | |
| ST001955 | AN003181 | Metabonomics analysis reveals the physiological mechanism of promoting maize shoots growth under negative pressure to stabilize soil water content | Leaf | Maize | Heilongjiang Bayi Agricultural University | APCI-MS | |
| ST001794 | AN002912 | Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples | Jejunum | Human | University of California, Davis | LC-MS | |
| ST001637 | AN002676 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001008 | AN001650 | Multi-Platform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity (part II) | Cecum | Mouse | Pennsylvania State University | LC-MS | |
| ST000867 | AN001396 | Metabolic Profiling of Date Palm Fruits (part II) | Date palm fruit | Date palm | Weill Cornell Medicine, Qatar | GC-MS/LC-MS | |
| ST000508 | AN000778 | Metabolic Profiling of Date Palm Fruits | Plant | Date palm | Weill Cornell Medicine, Qatar | GC-MS/LC-MS | |
| ST000231 | AN000346 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (part II) | Liver | Human | Cancer | Osaka City University | LC-MS |
| ST000230 | AN000344 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Liver | Human | Cancer | Osaka City University | LC-MS |